118 related articles for article (PubMed ID: 23140113)
1. Blinding in clinical trials: a practical approach.
Bang H; Park JJ
J Altern Complement Med; 2013 Apr; 19(4):367-9. PubMed ID: 23140113
[TBL] [Abstract][Full Text] [Related]
2. Blinding in randomised trials: hiding who got what.
Schulz KF; Grimes DA
Lancet; 2002 Feb; 359(9307):696-700. PubMed ID: 11879884
[TBL] [Abstract][Full Text] [Related]
3. Placebo surgery research: a blinding imperative.
Heckerling PS
J Clin Epidemiol; 2006 Sep; 59(9):876-80. PubMed ID: 16895807
[TBL] [Abstract][Full Text] [Related]
4. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.
Devereaux PJ; Choi PT; El-Dika S; Bhandari M; Montori VM; Schünemann HJ; Garg AX; Busse JW; Heels-Ansdell D; Ghali WA; Manns BJ; Guyatt GH
J Clin Epidemiol; 2004 Dec; 57(12):1232-6. PubMed ID: 15617948
[TBL] [Abstract][Full Text] [Related]
5. Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.
Houweling AH; Shapiro S; Cohen JM; Kahn SR
Clin Trials; 2014 Oct; 11(5):547-52. PubMed ID: 24902921
[TBL] [Abstract][Full Text] [Related]
6. Assessment of blinding in clinical trials.
Bang H; Ni L; Davis CE
Control Clin Trials; 2004 Apr; 25(2):143-56. PubMed ID: 15020033
[TBL] [Abstract][Full Text] [Related]
7. Blinding terminology used in reports of randomized controlled trials involving dogs and cats.
Giuffrida MA; Agnello KA; Brown DC
J Am Vet Med Assoc; 2012 Nov; 241(9):1221-6. PubMed ID: 23078571
[TBL] [Abstract][Full Text] [Related]
8. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.
Boutron I; Tubach F; Giraudeau B; Ravaud P
J Clin Epidemiol; 2004 Jun; 57(6):543-50. PubMed ID: 15246122
[TBL] [Abstract][Full Text] [Related]
9. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
[TBL] [Abstract][Full Text] [Related]
10. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
Haahr MT; Hróbjartsson A
Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
[TBL] [Abstract][Full Text] [Related]
11. Blinding in randomized clinical trials: imposed impartiality.
Hróbjartsson A; Boutron I
Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
[TBL] [Abstract][Full Text] [Related]
12. Is it possible to blind a trial for community-acquired pneumonia?
Boucher HW
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S210-5. PubMed ID: 18986292
[TBL] [Abstract][Full Text] [Related]
13. Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?
Webster RK; Bishop F; Collins GS; Evers AWM; Hoffmann T; Knottnerus JA; Lamb SE; Macdonald H; Madigan C; Napadow V; Price A; Rees JL; Howick J
J Clin Epidemiol; 2021 Jul; 135():176-181. PubMed ID: 33662512
[TBL] [Abstract][Full Text] [Related]
14. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
Fergusson D; Glass KC; Waring D; Shapiro S
BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of ST36 acupuncture for infantile colic.
Skjeie H; Skonnord T; Fetveit A; Brekke M
Acupunct Med; 2011 Jun; 29(2):103-7. PubMed ID: 21450707
[TBL] [Abstract][Full Text] [Related]
16. Ethical pitfalls in neonatal comparative effectiveness trials.
Modi N
Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
[TBL] [Abstract][Full Text] [Related]
17. Interpreting HIV clinical trials.
Glesby MJ
AIDS Clin Care; 1999 Jul; 11(7):58-9. PubMed ID: 11366435
[TBL] [Abstract][Full Text] [Related]
18. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
Walter SD; Awasthi S; Jeyaseelan L
Contemp Clin Trials; 2005 Aug; 26(4):459-68. PubMed ID: 16054578
[TBL] [Abstract][Full Text] [Related]
19. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.
Boutron I; Guittet L; Estellat C; Moher D; Hróbjartsson A; Ravaud P
PLoS Med; 2007 Feb; 4(2):e61. PubMed ID: 17311468
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach.
Bajard A; Chabaud S; Pérol D; Boissel JP; Nony P
Contemp Clin Trials; 2009 Sep; 30(5):400-10. PubMed ID: 19576298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
